COVID-19 Associated Acute Necrotizing Pancreatitis with Normal Serum Amylase and Lipase Levels: Report of an Unusual Finding.

Hemanth Sudarsanam, Dillibabu Ethiraj, Navaneetha Kumar Govarthanan, Srinivasan Kalyanasundaram, Sathya Arunachalam Chitra, Saisurendar Mohan
Author Information
  1. Hemanth Sudarsanam: Department of Radio-diagnosis, Dr. Rela Institute and Medical Centre, Chennai, India.
  2. Dillibabu Ethiraj: Department of Radio-diagnosis, Dr. Rela Institute and Medical Centre, Chennai, India.
  3. Navaneetha Kumar Govarthanan: Department of Radio-diagnosis, Dr. Rela Institute and Medical Centre, Chennai, India.
  4. Srinivasan Kalyanasundaram: Department of Radio-diagnosis, Dr. Rela Institute and Medical Centre, Chennai, India.
  5. Sathya Arunachalam Chitra: Department of Critical Care Medicine, Dr. Rela Institute and Medical Centre, Chennai, India.
  6. Saisurendar Mohan: Department of Emergency Medicine, Dr. Rela Institute and Medical Centre, Chennai, India.

Abstract

Coronaviruses are a large family of single-stranded RNA viruses infecting humans and animals, causing a multitude of symptoms. COVID-19 is not only known to affect the respiratory system, but shows unusual gastrointestinal complications. Pancreatitis can be caused by biliary stones, alcohol abuse, viruses, drug intake, metabolic syndromes, or trauma. Diagnosis of acute pancreatitis requires any two of the three criteria: acute onset of severe upper abdominal pain, consistent with pancreatitis; elevation of serum amylase or lipase, three times the upper limit of normal; and/or characteristic imaging findings. COVID-19 associated pancreatitis is thought to be mediated by the angiotensin-converting enzyme-2 receptor on the host cells, which are highly expressed in the pancreatic cells. Here, we report a unique case of acute necrotizing pancreatitis caused by COVID-19 with hyperglycemia and normal amylase and lipase levels.

Keywords

References

  1. Radiographics. 2014 Sep-Oct;34(5):1218-39 [PMID: 25208277]
  2. Am J Emerg Med. 2016 May;34(5):940.e5-7 [PMID: 26521195]
  3. JOP. 2010 Jul 05;11(4):369-72 [PMID: 20601812]
  4. PLoS One. 2013 Jun 24;8(6):e67454 [PMID: 23826303]
  5. Pancreatology. 2020 Jul;20(5):1013-1014 [PMID: 32498973]
  6. World J Gastrointest Surg. 2019 Apr 27;11(4):198-217 [PMID: 31123558]
  7. Emerg Med J. 2006 Sep;23(9):701-2 [PMID: 16921084]
  8. Gastroenterology Res. 2017 Jun;10(3):153-158 [PMID: 28725301]
  9. Am Fam Physician. 2007 May 15;75(10):1513-20 [PMID: 17555143]
  10. Cureus. 2020 Jul 13;12(7):e9169 [PMID: 32802606]
  11. World J Clin Cases. 2019 May 6;7(9):1006-1020 [PMID: 31123673]
  12. Gastroenterology. 2020 Jul;159(1):367-370 [PMID: 32247022]
  13. Pancreatology. 2010;10(2-3):222-8 [PMID: 20484959]

Word Cloud

Created with Highcharts 10.0.0COVID-19pancreatitisPancreatitisacutevirusescausedthreeupperamylaselipasenormalcellsAcuteNecrotizingCoronaviruseslargefamilysingle-strandedRNAinfectinghumansanimalscausingmultitudesymptomsknownaffectrespiratorysystemshowsunusualgastrointestinalcomplicationscanbiliarystonesalcoholabusedrugintakemetabolicsyndromestraumaDiagnosisrequirestwocriteria:onsetsevereabdominalpainconsistentelevationserumtimeslimitand/orcharacteristicimagingfindingsassociatedthoughtmediatedangiotensin-convertingenzyme-2receptorhosthighlyexpressedpancreaticreportuniquecasenecrotizinghyperglycemialevelsAssociatedNormalSerumAmylaseLipaseLevels:ReportUnusualFindingCoronavirusTomography

Similar Articles

Cited By